Evidence map›Paper›PMID 34679086›Full record

ArticlePloS one2021

Investigating single amino acid substitutions in PIM1 kinase: A structural genomics approach.

Alaa Shafie, Shama Khan, Sagar Batra, Farah Anjum, Taj Mohammad, Shoaib Alam, Dharmendra Kumar Yadav, Asimul Islam, Md Imtaiyaz Hassan

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Alaa ShafieDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia.
Shama KhanDrug Discovery and Development Centre (H3D), University of Cape Town, Rondebosch, Cape Town, South Africa.
Sagar BatraAmity Institute of Biotechnology, Amity University Rajasthan, Jaipur, Rajasthan, India.ORCID 0000-0003-3986-5047
Farah AnjumDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia.ORCID 0000-0002-8597-6015
Taj MohammadCentre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India.ORCID 0000-0002-0399-4835
Shoaib AlamDepartment of Biotechnology, Jamia Millia Islamia, Jamia Nagar, New Delhi, India.
Dharmendra Kumar YadavCollege of Pharmacy, Gachon University of Medicine and Science, Yeonsu-gu, Incheon City, South Korea.ORCID 0000-0003-1102-1993
Asimul IslamCentre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India.ORCID 0000-0001-9060-7970
Md Imtaiyaz HassanCentre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India.ORCID 0000-0002-3663-4940
Jamia Millia Islamia · INTaif University · SADepartment of Biotechnology · INGachon University · KRUniversity of Cape Town · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PIM1, is a serine/threonine proto-oncogene kinase, involved in many biological functions, including cell survival, proliferation, and differentiation, thus play a key role in oncogenesis. It plays a crucial role in the onset and progression of various hematopoietic and non-hematopoietic malignancies, including acute myeloid leukemia and prostate cancer. Mutations in PIM1, especially in its kinase domain, can induce abnormal structural changes and thus alter functionalities that can lead to disease progression and other complexities. Herein, we have performed an extensive analysis of the PIM1 mutations at sequence and structure level while utilizing state-of-the-art computational approaches. Based on the impact on PIM1, numerous pathogenic and destabilizing mutations were identified and subsequently analyzed in detail. Finally, two amino acid substitutions (W109C and F147C) in the kinase domain of PIM1 were selected to explore their impact on the PIM1 structure in a time evolution manner using all-atom molecular dynamics (MD) simulations for 200 ns. MD results indicate significant conformational altercations in the structure of PIM1, especially upon F147C mutation. This study provides a significant insight into the PIM1 dysfunction upon single amino acid substitutions, which can be utilized to get insights into the molecular basis of PIM1-associated disease progression.

Indexed as

Amino Acid SubstitutionMutationGenomicsHumansProto-Oncogene Proteins c-pim-1Proto-Oncogene Proteins c-pim-1

Identifiers

PMID34679086
PMCPMC8535467
OpenAlexW3207893114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.